Global health impacts of nanotechnology law : a tool for stakeholder engagement

목차 (Table of Contents)

• CONTENTS
• Books by the Same Author = xvii
• Foreword = xix
• Preface = xxi
• Introduction = xxxi
• 1 Big Questions about Defining Little Nanoparticles = 1
• 1.1 How Can Benefits of Nanotechnology Be Realized While Minimizing Risk? = 1
• 1.1.1 Simple Applications of Nanotechnology to Daily life = 9
• 1.1.2 An Illusion of Consensus : The "Nano" That "Everybody" Knows = 9
• 1.1.3 Labels : How Big Is Nano, How Small Is NOT Nano? = 14
• 1.1.4 Capturing Discovery : The Limits of Lists and Numbers as Regulatory Criteria = 19
• 1.2 What Is Nanotechnology? = 26
• 1.2.1 Sample Legal Definitions = 26
• 1.3 Invitation to Discovery : The Way Forward with Nanotechnology = 40
• 2 Lessons Learned from the Legend of Asbestos = 45
• 2.1 The Legend of Asbestos That Haunts Nanotechnology Law = 45
• 2.1.1 Policy Dilemma : No Substitute Works as Good or Harms as Bad as Asbestos = 57
• 2.1.2 The Case That Never Ends : Key Asbestos Litigation Including "Cancerphobia" = 68
• 2.1.3 Law of Significant Risk Limiting Dangerous Exposures = 70
• 2.2 Lessons Learned from Asbestos = 84
• 2.2.1 The Road Not Taken for Asbestos Regulation = 87
• 2.2.2 Components of International Regulation of Asbestos Exposure = 88
• 2.3 Nanotechnology Revolutionizing Risk Communication = 97
• 2.3.1 Due Diligence Is Your Best Friend = 98
• 2.3.2 Candor, Not Secrecy = 99
• 2.3.3 The Question Is Knowledge and Consent, Not the Magnitude of Risk = 101
• 3 Global Health Impacts : Nanotechnology Fighting Cancer and Disability = 111
• 3.1 Revolutionary Promises of Nanomedicine = 111
• 3.1.1 Nano World Cancer Day = 116
• 3.1.2 Benefits to Patients : New Bones, New Teeth, and New Organs = 116
• 3.1.3 New Technologies for HIV-Positive Communities Living with AIDS = 118
• 3.1.4 The Fair Share in Posterity for All : Assisted Reproductive Technologies Enabling LGBT Families = 119
• 3.2 Global Health Impacts : Improved Quality of Life for Children = 122
• 3.2.1 UN International Convention on the Rights of the Child = 123
• 3.2.2 Potential Consumer Exposures among Children = 128
• 3.3 Beauty Babies and Dieting : The Impact of Nanotechnology on Women&aposs Health = 131
• 3.3.1 Reducing the Global Disease Burden of Maternal Mortality = 132
• 3.3.2 International Convention on the Elimination of All Forms of Discrimination against Women : Friend or Foe of Pregnant Women? = 135
• 3.4 New Promise for Aging Populations = 141
• 3.4.1 A "Revolving Door" for Health Care of the Aging = 141
• 3.4.2 Ageless Reproductive Health = 146
• 4 Integrating Nanotechnology into International Laws Protecting Health = 153
• 4.1 An Abundance of International Laws : Resisting the Fad of Nanoregulation = 153
• 4.1.1 Health Protections under the United Nations Charter = 157
• 4.1.2 International Covenant on Economic, Social, and Cultural Rights = 160
• 4.1.3 The World Health Organization Constitution : Codifying Precautionary Principles = 162
• 4.1.4 The International Labour Organization = 179
• 4.1.5 The United Nations Environment Programme = 188
• 4.2 WTO Limitations Regarding Safety and Health for Trade Agreements = 191
• 4.3 OECD : Nanotechnology Protections across Industrialized Nations = 194
• 5 Nanotechnology&aposs Opportunity to Revolutionize Health for All = 205
• 5.1 Food for Thought = 207
• 5.1.1 Nanotechnology Impacts Our Daily Bread = 209
• 5.1.2 Impact on Religious Food = 211
• 5.2 Clothing and Being Beautiful = 221
• 5.2.1 Instant Clothing, New Textiles, New Dyes Creating Lighter, Stronger Fabrics = 221
• 5.2.2 Runway Fashion = 223
• 5.2.3 Cosmetics = 225
• 5.3 Shelter from the Storms = 226
• 5.3.1 Self-Cleaning Concrete = 227
• 5.3.2 Consumer and Workplace Paints and Coatings = 228
• 5.3.3 3D Printing for Housing Components = 228
• 5.4 Energy = 230
• 5.4.1 Smarter, Driverless Cars = 230
• 5.4.2 Reduced Energy Needs Favoring Environmental Health = 232
• 6 Stakeholders, One and All = 239
• 6.1 Public-Private Partnership Promoting Risk Management = 239
• 6.1.1 The Wide Range of Stakeholders in Civil Society = 241
• 6.1.2 Voluntary Compliance by Multinational Corporations = 243
• 6.1.3 The Role of Noncorporate Stakeholders in Society = 249
• 6.2 The Right to Know : A Conceptual Blueprint for Protecting Civilization = 252
• 6.2.1 The Right to Know and Hamilton&aposs Work Exploring the Dangerous Trades = 252
• 6.2.2 Consumer&aposs Right to Know and the GHS = 255
• 6.3 Hamilton&aposs Legacy : Government Obligations Operationalizing the Right to Know = 259
• 6.3.1 Seoul Declaration on Occupational Safety and Health = 259
• 6.3.2 Right to Know Embracing Nanotechnology = 260
• 7 Risk Governance for Regulatory Management of Nanotechnology = 271
• 7.1 International Efforts to Harness Nanomaterials under Law = 271
• 7.1.1 The Council of Europe = 274
• 7.1.2 Convention on the Prevention of Counterfeit Medicines and Medical Devices ("Medicrime") and Convention on Biomedicine and Human Rights = 277
• 7.1.3 International Collaboration for Nanosafety Research : A Global Issue = 283
• 7.1.4 European Union-U.S. Partnership = 286
• 7.1.5 ERA-NET SIINN Harmonizing European Standards Regarding Nanotechnology Precautionary Principles and NanoReg2 = 288
• 7.2 The New Model for Risk Governance : Risk Management and Risk Mitigation = 289
• 7.2.1 Design Components of Risk Management Systems = 292
• 7.2.2 Selling the Program : Communication Is a Two-Way Street = 293
• 7.3 The Nuts and Bolts of Risk Management : Corporate Compliance Programs = 295
• 7.3.1 How? = 297
• 7.3.2 The Hierarchy of Engineering Controls = 299
• 8 Bioethical Impacts : Nanotechnology Transforming Disability into Health = 311
• 8.1 Rethinking Traditional Policies : Nanotechnology Impacting Health and Work as Part of the Human Condition = 311
• 8.1.1 What Is Health? = 317
• 8.1.2 What Is Work? = 318
• 8.1.3 What Is Nonhealth or Disability? = 322
• 8.2 Voluntariness or Choice in Major Life Decisions = 323
• 8.2.1 Principles of Exposure to Risk : Employer Responsibility for Recognized Hazards = 325
• 8.2.2 Redefining Choice in Maternal and Child Health Laws = 326
• 8.2.3 ART in Laws about Parenting, Including LGBTI Communities = 327
• 8.2.4 Autonomous Choices about Prolonging or Ending Life = 328
• 8.3 Who Needs Law? = 331
• 8.3.1 The New Paradigm for Rights of People with Disabilities under International Law = 332
• 8.3.2 Bringing Health to Work for People with Disabilities = 334
• 8.3.3 Redefining Life and Work = 337
• 9 Forethought Beats Afterthought = 347
• 9.1 "There Oughtta Be a Law." = 347
• 9.1.1 Legislative Drafting Solutions : Benefits of Using Criteria That Avoid Definitions, Numbers, or Labels = 350
• 9.1.2 Chart : Key Points for Legislation Harmonizing Nanotechnology Standards = 355
• 9.2 Stakeholder Tools for Translating Scientific Consensus into Governance for Nanomaterials = 358
• 9.2.1 Syllabus of "Nanotechnology Law and Health Policy : Science Serving Society" = 361
• 9.2.2 City of Cambridge Nanomaterial Use Survey = 370
• 9.3 There "Oughtta Be" a Law : A Stakeholder Simulation of the "Nano-Law" Debate = 373
• 9.3.1 The Players = 376
• 10 There Oughtta Be a Law = 383
• 10.1 Synthesizing Nanotechnology Advances into Harmonized Legislative Text = 383
• 10.2 Nanotechnology Risk Management and Public Health Protection Act Model = 384
• 10.2.1 Section 1 : Legislative Findings = 384
• 10.2.2 Section 2 : Purposes = 393
• 10.2.3 Section 3 : Definitions = 394
• 10.2.4 Section 4 : Scope = 396
• 10.2.5 Section 5 : Commission Established = 397
• 10.2.6 Section 6 : Rewards for Proven Due Diligence in Risk Management = 401
• 10.2.7 Section 7 : Risk Management to Promote Responsible Development of Nanotechnology = 401
• 10.2.8 Section 8 : Integration with the GHS = 404
• 10.2.9 Section 9 : Enforcement Provisions = 405
• 10.2.10 Section 10 : Penalties = 405
• 10.2.11 Section 11 : Saving Clause = 407
• 10.2.12 Section 12 : Effective Date = 407
• 10.3 Keeping the Canary Alive with Safe and Healthful Uses of Nanotechnology : Birthright or Gift to Humanity? = 408
• Acknowledgments with Gratitude! = 415
• Index = 423